Last reviewed · How we verify

Multiple injection local anesthetic

Hôpital du Valais · FDA-approved active Small molecule

Local anesthetics block sodium channels in nerve fibers, preventing the initiation and propagation of action potentials to produce localized numbness and pain relief.

Local anesthetics block sodium channels in nerve fibers to prevent the initiation and propagation of action potentials, thereby producing reversible loss of sensation in a localized area. Used for Local anesthesia for minor surgical procedures, Local anesthesia for dental procedures, Local anesthesia for pain management.

At a glance

Generic nameMultiple injection local anesthetic
SponsorHôpital du Valais
Drug classLocal anesthetic
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaAnesthesia
PhaseFDA-approved

Mechanism of action

Local anesthetics reversibly inhibit sodium influx through voltage-gated sodium channels in nerve cell membranes, thereby preventing depolarization and nerve impulse transmission in the injected area. This effect is localized to the site of injection and surrounding tissues, producing anesthesia without systemic effects when used appropriately. Multiple injections allow for extended anesthetic coverage across a larger anatomical region.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: